How Genetic Testing for Chronic Kidney Disease Improves Transplant Success
Broad-based genetic testing gives clinicians better insights into chronic kidney disease, improving the odds of a good transplant outcome.
Broad-based genetic testing gives clinicians better insights into chronic kidney disease, improving the odds of a good transplant outcome.
Metabolites in the blood whose levels are altered by coffee consumption and may contribute to risk of developing chronic kidney disease.
The NephroCheck test relies on the detection of two urinary biomarkers: TIMP-2 and IGFBP-7. Both are produced by stressed kidney cells before the onset of AKI.
The NGAL protein has been designed to provide a high level of purity that minimizes the risk of interferences due to contaminants.
Read MoreImmunoassay developers are staying current with new releases year round.
Read MoreWorkshop attendees can expect to understand improvements in CKD diagnostic testing, and to examine other opportunities for analytical improvement focusing on the measurement of bone markers, parathyroid hormone, and vitamin D compounds.
Read MoreTo determine how recommendations for chronic kidney disease testing in laboratory and point-of-care environments are shifting, CLP spoke to Robert H. Christenson, PhD, professor of pathology and medical and research technology at the University of Maryland School of Medicine and past president of the American Association for Clinical Chemistry.
Read MoreOrtho-Clinical Diagnostics has announced the availability of the NephroCheck test system, the first such test designed to help healthcare providers identify patients at risk of developing moderate or severe acute kidney injury within 12 hours of assessment.
Read MoreWith the prevalence of diabetes continuing on an upward trajectory both in the United States and overseas, healthcare professionals are continuing to search for more effective methods of preventing, detecting, and treating the disease.
Read MoreFDA has granted market clearance for the first test that can help determine whether membranous glomerulonephritis is due to the body’s rejection of its own kidney tissue (autoimmune) or to another cause, such as infection.
Read MoreThe company produces comprehensive third-party designer drug quality controls for use with any methodology, on any testing platform.
Read MoreExamining 12 major types of cancer, scientists at Washington University School of Medicine in St Louis have identified 127 repeatedly mutated genes that appear to drive the development and progression of a range of tumors in the body.
Read MoreResearchers at Moffitt Cancer Center, Tampa, Fla, and colleagues at the University of South Florida have discovered a mechanism that explains how some cancer cells hijack a biological process to potentially activate cell growth and the survival of cancer gene expression.
Read MoreThroughout 2012, the American Association for Clinical Chemistry will be exploring best laboratory practices for detecting and managing four high-prevalence disease states.
Read MoreThe American Association for Clinical Chemistry (AACC) will host 12 Webinars on high-value tests for high-impact diseases.
Read MoreTesting options are growing with the proliferation of HbA1c.
Read MoreWith the participation of the two largest US dialysis companies, Rockwell Medical will conduct two pivotal Phase 3 trials for Soluble Ferric Pyrophosphate as a continuous iron-replacement therapeutic.
Read MoreFormer US Senate majority leader Bill Frist, MD, sits down with CLP to discuss what personalized medicine will mean for labs.
Read More